Impact of an enhanced recovery after surgery pathway on thoracoscopic lobectomy outcomes in non-small cell lung cancer patients: a propensity score-matched study.
Video-assisted thoracic surgery (VATS)
enhanced recovery after surgery (ERAS)
lobectomy
non-small cell lung cancer (NSCLC)
thoracoscopy
Journal
Translational lung cancer research
ISSN: 2218-6751
Titre abrégé: Transl Lung Cancer Res
Pays: China
ID NLM: 101646875
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
entrez:
11
2
2021
pubmed:
12
2
2021
medline:
12
2
2021
Statut:
ppublish
Résumé
This study evaluates the effect of enhanced recovery after surgery (ERAS) pathways on postoperative outcomes of non-small cell lung cancer (NSCLC) patients undergoing video-assisted thoracic surgery (VATS) lobectomy. We retrospectively reviewed all consecutive patients undergoing VATS lobectomy for NSCLC between January 2014 and October 2019 and assigned them to the relevant group ("pre-ERAS" or "ERAS"). Length of stay, readmissions and complications within 30 days were compared between both groups. A propensity score-matched analysis was performed based on sex, age, type of operation, comorbidities, American Society of Anesthesiologists (ASA) score and preoperative pulmonary functions. A total of 307 records (164 male/143 female; 140 ERAS/167 pre-ERAS; median age: 67) were reviewed. There was no statistical difference in patient's characteristics. Overall ERAS compliance was 81%. The ERAS group presented significantly shorter length of stay (median 5 Adoption of an ERAS pathway for VATS lobectomies in NSCLC patients has decreased the length of hospital stay and the cardiopulmonary complication rate without affecting the readmission rate.
Sections du résumé
BACKGROUND
BACKGROUND
This study evaluates the effect of enhanced recovery after surgery (ERAS) pathways on postoperative outcomes of non-small cell lung cancer (NSCLC) patients undergoing video-assisted thoracic surgery (VATS) lobectomy.
METHODS
METHODS
We retrospectively reviewed all consecutive patients undergoing VATS lobectomy for NSCLC between January 2014 and October 2019 and assigned them to the relevant group ("pre-ERAS" or "ERAS"). Length of stay, readmissions and complications within 30 days were compared between both groups. A propensity score-matched analysis was performed based on sex, age, type of operation, comorbidities, American Society of Anesthesiologists (ASA) score and preoperative pulmonary functions.
RESULTS
RESULTS
A total of 307 records (164 male/143 female; 140 ERAS/167 pre-ERAS; median age: 67) were reviewed. There was no statistical difference in patient's characteristics. Overall ERAS compliance was 81%. The ERAS group presented significantly shorter length of stay (median 5
CONCLUSIONS
CONCLUSIONS
Adoption of an ERAS pathway for VATS lobectomies in NSCLC patients has decreased the length of hospital stay and the cardiopulmonary complication rate without affecting the readmission rate.
Identifiants
pubmed: 33569296
doi: 10.21037/tlcr-20-891
pii: tlcr-10-01-93
pmc: PMC7867780
doi:
Types de publication
Journal Article
Langues
eng
Pagination
93-103Informations de copyright
2021 Translational Lung Cancer Research. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tlcr-20-891). The authors have no conflicts of interest to declare.
Références
J Surg Res. 2019 Mar;235:521-528
pubmed: 30691838
J Thorac Cardiovasc Surg. 2017 Dec;154(6):2084-2090
pubmed: 28728783
Surg Endosc. 2011 Apr;25(4):1263-9
pubmed: 20927543
Int J Gynecol Cancer. 2019 May;29(4):651-668
pubmed: 30877144
J Thorac Cardiovasc Surg. 2014 Aug;148(2):637-43
pubmed: 24529729
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Ann Thorac Surg. 2018 Jul;106(1):272-279
pubmed: 29530770
Surgery. 2015 Oct;158(4):899-908; discussion 908-10
pubmed: 26189953
Chest. 2013 May;143(5 Suppl):e278S-e313S
pubmed: 23649443
Ann Surg. 2015 Jan;261(1):92-6
pubmed: 24646564
Ann Thorac Surg. 2017 Sep;104(3):950-957
pubmed: 28778343
Ann Surg. 2019 Dec 5;:
pubmed: 31851005
Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1192-1198
pubmed: 29584928
J Thorac Cardiovasc Surg. 2010 Feb;139(2):366-78
pubmed: 20106398
Gen Thorac Cardiovasc Surg. 2020 Sep;68(9):1003-1010
pubmed: 32166579
Ann Thorac Surg. 2008 Dec;86(6):2008-16; discussion 2016-8
pubmed: 19022040
Br J Surg. 2014 Sep;101(10):1209-29
pubmed: 25047143
JAMA Oncol. 2015 Jul;1(4):505-27
pubmed: 26181261
Dis Colon Rectum. 2013 May;56(5):667-78
pubmed: 23575408
World J Surg. 2013 Feb;37(2):259-84
pubmed: 23052794
Eur J Cardiothorac Surg. 2016 Feb;49(2):602-9
pubmed: 25913824
J Thorac Dis. 2018 Oct;10(10):5879-5888
pubmed: 30505496
Eur J Cardiothorac Surg. 2016 Mar;49(3):870-5
pubmed: 26088592
J Cardiothorac Vasc Anesth. 2020 Jul;34(7):1858-1866
pubmed: 32139340
J Thorac Cardiovasc Surg. 2019 Jul;158(1):279-286.e1
pubmed: 31014665
Cancer Manag Res. 2017 Nov 16;9:657-670
pubmed: 29180901
Eur J Cardiothorac Surg. 2019 Jan 1;55(1):91-115
pubmed: 30304509
Ann Thorac Surg. 2018 Jun;105(6):1597-1604
pubmed: 29510097
Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007635
pubmed: 21328298
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1843-1852
pubmed: 29352586
J Thorac Dis. 2019 Mar;11(Suppl 4):S515-S522
pubmed: 31032070
Can J Surg. 2020 May 08;63(3):E233-E240
pubmed: 32386474